Literature DB >> 26230477

"Rescue" of bilateral subthalamic stimulation by bilateral pallidal stimulation: case report.

Caio M Matias1,2, Danilo Silva1, Andre G Machado1, Scott E Cooper1.   

Abstract

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) orglobus pallidus pars interna (GPi) is well established as a treatment for advanced Parkinson's disease. In general, one of the 2 targets is chosen based on the clinical features of each patient. Stimulation of both targets could be viewed as redundant, given that the 2 targets are directly connected. However, it is possible that each target has different mechanisms, with clinical effects mediated by orthodromic or antidromic stimulation. The authors report the case of a patient with severe Parkinson's disease who had previously undergone bilateral subthalamic stimulation with excellent benefits. However, he presented with significant worsening associated with disease progression and pharmacological treatment, and then underwent bilateral GPi DBS. Follow-up assessment was conducted clinically as well as through blinded ratings of video recordings. Pallidal DBS may be a safe and useful strategy to manage dystonic features and behavioral complications of subthalamic stimulation and pharmacological management. While combined stimulation was quite successful in the reported patient, further studies with larger samples and longer follow-up periods will be necessary before recommending the addition of pallidal DBS as a routine strategy for patients previously implanted with STN DBS.

Entities:  

Keywords:  DBS = deep brain stimulation; GPi = globus pallidus pars interna; IPG = implantable pulse generator; LEDD = levodopa equivalent daily dose; MDS-UPDRS = Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale; NRS-11 = 0- to 10-point Numerical Rating Scale; PD = Parkinson’s disease; PW = pulse width; Parkinson’s disease; STN = subthalamic nucleus; deep brain stimulation; dual target; functional neurosurgery; globus pallidus; subthalamic nucleus

Mesh:

Year:  2015        PMID: 26230477     DOI: 10.3171/2015.1.JNS141604

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  The Emerging Role of Biomarkers in Adaptive Modulation of Clinical Brain Stimulation.

Authors:  Kimberly B Hoang; Dennis A Turner
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

2.  Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S.

Authors:  Kyle T Mitchell; Stephen L Schmidt; Jeffrey W Cooney; Warren M Grill; Jennifer Peters; Shervin Rahimpour; Hui-Jie Lee; Sin-Ho Jung; Sneha Mantri; Burton Scott; Shivanand P Lad; Dennis A Turner
Journal:  Neurosurgery       Date:  2022-04-07       Impact factor: 5.315

Review 3.  Rescue Procedures after Suboptimal Deep Brain Stimulation Outcomes in Common Movement Disorders.

Authors:  Adam M Nagy; Christopher M Tolleson
Journal:  Brain Sci       Date:  2016-10-08

4.  The "curved lead pathway" method to enable a single lead to reach any two intracranial targets.

Authors:  Chen-Yu Ding; Liang-Hong Yu; Yuan-Xiang Lin; Fan Chen; Zhang-Ya Lin; De-Zhi Kang
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

Review 5.  Biomarkers and Stimulation Algorithms for Adaptive Brain Stimulation.

Authors:  Kimberly B Hoang; Isaac R Cassar; Warren M Grill; Dennis A Turner
Journal:  Front Neurosci       Date:  2017-10-10       Impact factor: 4.677

Review 6.  Comparison of Globus Pallidus Interna and Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease: An Institutional Experience and Review.

Authors:  Shazia Mirza; Umar Yazdani; Richard Dewey Iii; Neepa Patel; Richard B Dewey; Svjetlana Miocinovic; Shilpa Chitnis
Journal:  Parkinsons Dis       Date:  2017-06-19

7.  Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure.

Authors:  Juan Miguel Pilar Bautista; Genko Oyama; Maierdanjiang Nuermaimaiti; Satoko Sekimoto; Fuyuko Sasaki; Taku Hatano; Kenya Nishioka; Masanobu Ito; Atsushi Umemura; Yuji Ishibashi; Yasushi Shimo; Nobutaka Hattori
Journal:  J Mov Disord       Date:  2020-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.